Literature DB >> 23400815

Movement disorders in adult patients with classical galactosemia.

Ignacio Rubio-Agusti1, Miryam Carecchio, Kailash P Bhatia, Maja Kojovic, Isabel Parees, Hoskote S Chandrashekar, Emma J Footitt, Derek Burke, Mark J Edwards, Robin H L Lachmann, Elaine Murphy.   

Abstract

Classical galactosemia is an autosomal recessive inborn error of metabolism leading to toxic accumulation of galactose and derived metabolites. It presents with acute systemic complications in the newborn. Galactose restriction resolves these symptoms, but long-term complications, such as premature ovarian failure and neurological problems including motor dysfunction, may occur despite adequate treatment. The objective of the current study was to determine the frequency and phenotype of motor problems in adult patients with classical galactosemia. In this cross-sectional study, adult patients with a biochemically confirmed diagnosis of galactosemia attending our clinic were assessed with an interview and neurological examination and their notes retrospectively reviewed. Patients were classified according to the presence/absence of motor dysfunction on examination. Patients with motor dysfunction were further categorized according to the presence/absence of reported motor symptoms. Forty-seven patients were included. Thirty-one patients showed evidence of motor dysfunction including: tremor (23 patients), dystonia (23 patients), cerebellar signs (6 patients), and pyramidal signs (4 patients). Tremor and dystonia were often combined (16 patients). Thirteen patients reported motor symptoms, with 8 describing progressive worsening. Symptomatic treatment was effective in 4 of 5 patients. Nonmotor neurological features (cognitive, psychiatric, and speech disorders) and premature ovarian failure were more frequent in patients with motor dysfunction. Motor dysfunction is a common complication of classical galactosemia, with tremor and dystonia the most frequent findings. Up to one third of patients report motor symptoms and may benefit from appropriate treatment. Progressive worsening is not uncommon and may suggest ongoing brain damage in a subset of patients.
Copyright © 2013 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400815     DOI: 10.1002/mds.25348

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  21 in total

Review 1.  Appropriateness of newborn screening for classic galactosaemia: a systematic review.

Authors:  L Varela-Lema; L Paz-Valinas; G Atienza-Merino; R Zubizarreta-Alberdi; R Vizoso Villares; M López-García
Journal:  J Inherit Metab Dis       Date:  2016-04-26       Impact factor: 4.982

2.  D-Galactose Causes Motor Coordination Impairment, and Histological and Biochemical Changes in the Cerebellum of Rats.

Authors:  André Felipe Rodrigues; Helena Biasibetti; Bruna Stela Zanotto; Eduardo Farias Sanches; Felipe Schmitz; Vinícius Tejada Nunes; Paula Pierozan; Vanusa Manfredini; Débora Delwing Dal Magro; Carlos Alexandre Netto; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

3.  [Central myelination disorder in classical galactosemia : Case report of two sisters].

Authors:  C D Reimers; S Hähnel; C Terborg
Journal:  Nervenarzt       Date:  2017-02       Impact factor: 1.214

4.  Bone Health in Classic Galactosemia: Systematic Review and Meta-Analysis.

Authors:  Britt van Erven; Lindsey Welling; Sandra C van Calcar; Artemis Doulgeraki; François Eyskens; Joanna Gribben; Eileen P Treacy; Rein Vos; Susan E Waisbren; M Estela Rubio-Gozalbo; Annet M Bosch
Journal:  JIMD Rep       Date:  2016-12-20

5.  Assessment of ataxia phenotype in a new mouse model of galactose-1 phosphate uridylyltransferase (GALT) deficiency.

Authors:  Wyman Chen; Rose Caston; Bijina Balakrishnan; Anwer Siddiqi; Kamalpreet Parmar; Manshu Tang; Merry Feng; Kent Lai
Journal:  J Inherit Metab Dis       Date:  2016-10-25       Impact factor: 4.982

6.  Systematic Review and Meta-analysis of Intelligence Quotient in Early-Treated Individuals with Classical Galactosemia.

Authors:  Lindsey Welling; Susan E Waisbren; Kevin M Antshel; Hugh-Owen Colhoun; Matthias Gautschi; Stephanie Grünewald; Rebecca Holman; Johanna H van der Lee; Eileen P Treacy; Annet M Bosch
Journal:  JIMD Rep       Date:  2017-04-09

7.  Coordinated movement, neuromuscular synaptogenesis and trans-synaptic signaling defects in Drosophila galactosemia models.

Authors:  Patricia P Jumbo-Lucioni; William M Parkinson; Danielle L Kopke; Kendal Broadie
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150

8.  Friedreich Ataxia in Classical Galactosaemia.

Authors:  Siobhán Neville; Siobhan O'Sullivan; Bronagh Sweeney; Bryan Lynch; Donncha Hanrahan; Ina Knerr; Sally Ann Lynch; Ellen Crushell
Journal:  JIMD Rep       Date:  2015-07-29

9.  Revised proposal for the prevention of low bone mass in patients with classic galactosemia.

Authors:  Britt van Erven; Myrna M M Römers; M Estela Rubio-Gozalbo
Journal:  JIMD Rep       Date:  2014-08-03

10.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.